Navigation Links
Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting

s such as interleukin-2. They are designed to increase the uptake of cancer therapeutics at the tumor site, thereby increasing anti-tumor efficacy without having to increase the dose and risk greater toxicity. The novel R&D methods described by Peregrine scientists enabled the company to identify potential VEA clinical candidates for further evaluation in animal cancer models. * Peregrine researchers also reported on their successful efforts to develop second-generation fully humanized anti-PS antibodies for possible use in a variety of Peregrine development programs. Data assessing the fully human version of the antibody indicated that it was equivalent to the current chimeric version. Fully humanized antibodies may have advantages in some applications and also provide Peregrine with greater flexibility in designing and differentiating new drug candidates.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs for HCV infection and a range of solid cancers in the U.S. and India with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intent
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
4. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
5. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
11. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/28/2015)... Aug. 28, 2015  CytomX Therapeutics, Inc., a biopharmaceutical ... today announced the filing of a registration statement on ... (SEC) relating to a proposed initial public offering of ... offered and the price range for the offering have ... common stock under the symbol "CTMX" on the NASDAQ ...
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Bevacizumab Market ,2010-2019" report ... the trade name of Avastin, bevacizumab injection is the ... it was approved by CFDA to treat metastatic colorectal ... all come from Roche and its subsidiary ...
(Date:8/28/2015)... 28, 2015  Today, in final recognition of the ... Health Week, 1-800 Contacts is sharing how to keep ... lens wearers who do not properly care for their ... infections. Most contact lens wearers understand ... clean lens case is sometimes overlooked.  When proper steps ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2
... Reportlinker.com announces that a new market ... Stakeholder Opinions: Vaccines in ... Brazil, Mexico and Argentina ... the past decade, vaccines have resurfaced as ...
... Md., Nov. 4, 2010 The U.S. Food and ... pathway to market for mammography systems that produce computerized ...   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ... Digital Mammography Systems, are an alternative to mammography systems ...
Cached Medicine Technology:Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 2Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 3Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 5Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 6Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 7Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 8FDA Reclassifies Certain Digital Mammography Devices 2FDA Reclassifies Certain Digital Mammography Devices 3
(Date:8/30/2015)... San Francisco, CA (PRWEB) , ... August 31, ... ... half of U.S. jobs and a third of tax receipts, issues that are ... business. Large corporations have bands of attorneys and lobbyists monitoring proposed legislation and ...
(Date:8/30/2015)... , ... August 31, 2015 , ... ... Integrated Systems announces specific strategies to help assisted living facilities and nursing homes ... from break-ins and theft. According to security experts at the company, security systems ...
(Date:8/30/2015)... ... August 30, 2015 , ... Scientists in France say ... a range of digestive cancers. Surviving Mesothelioma has just posted an article on the ... University of Caen measured the cancer incidence among 2,024 French asbestos plant workers from ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products International ( http://www.nutricompany.com ... of global cosmeceutical and skin care brands. Mr. Fernandez comes with a ... years working in operations, purchasing and management for some of the nations biggest ...
(Date:8/29/2015)... ... 2015 , ... On September 30, 2015, the Career and Transfer Center (CTC) ... Maricopa Community Colleges , will be hosting a Job Expo to provide a ... opportunities. , The Expo has expanded to much more than just a typical job ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 3Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 4Health News:Total Security Announces Security Systems Tips for New York Assisted Living Facilities and Nursing Homes 2Health News:Total Security Announces Security Systems Tips for New York Assisted Living Facilities and Nursing Homes 3Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2
... BOZEN, Italy, September 21 Health Robotics ... strategic partnership,with Device Technologies Australia Pty Ltd. for ... Technologies,Australia to achieve its goal of safely, accurately ... to complement its,other market-leading Oncology and Surgery Robotic ...
... 21 /PRNewswire-FirstCall/ - Equity Capital Management (ECM) ... review of the HTDS business model. ECM ... HTDS followers at the following link ... (ECM) believes that in the current economic ...
... , ... Helps Organizations Achieve Lower TCO by Streamlining IT Audit Processes, Harmonizing Controls with Policy Requirements, ... ... , , , , ,News Facts:, , ,A typical organization spends 30-50% more ...
... , , NEW ... new prior art impacting the validity of two Minerva Industries, ... also announced the discovery of new evidence which can show ... as verified by outside counsel. The discovery of this patent ...
... , ST. LOUIS, Sept. 21 ... sale to Perrigo Company (Nasdaq: PRGO ) of KV,s ... Food and Drug Administration for a generic equivalent version of GlaxoSmithKline,s ... of the transaction, KV will receive $14 million from Perrigo at ...
... Sept. 21 /EIN News/ According to the Web site Raw ... Clinton administration Philip Morris "worked off-the-record with . . . writer ... been partly funded by a huge increase in tobacco taxes. , ... term "death panels" used by anti-healthcare reform activists determined to scuttle ...
Cached Medicine News:Health News:Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australia's Strategic Partnership 2Health News:Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australia's Strategic Partnership 3Health News:Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases (HTDS) 2Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 2Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 3Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 4Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 5Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 6Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 7Health News:Minerva and Cymbalta Patent Invalidity Evidence Uncovered by Article One Partners Community 2Health News:Minerva and Cymbalta Patent Invalidity Evidence Uncovered by Article One Partners Community 3Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 2Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 3Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 4Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 5Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 6Health News:'Death Panel' Inventor & Critic of Healthcare Reform Betsy McCaughey 'Has Close Ties' to Philip Morris; Healthcare Industry Today Offers Complete Coverage 2
... This is one of our highly featured models. This ... select a target using the mouse to have the ... that will allow the unit to photograph a particular ... is that after you have taken the picture you ...
... The VersaPulse PowerSuite holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... of compact CO2 systems available from LumenisTM ... 40 watts combines portability with uncompromised ... laser beam, as well as SuperPulseTM operation ... small operating theatres and are easily transported ...
... the progress and perfecting of endourological techniques ... a more strategic role in the urological ... sector has certainly contributed towards simplifying and ... that are becoming more and more prevalent ...
Medicine Products: